Word

STEBRONIX

Status

Dead

Status Code

710

Status Date

Friday, November 25, 2022

Serial Number

86703953

Registration Number

4954560

Registration Date

Tuesday, May 10, 2016

Mark Type

4000

Filing Date

Friday, July 24, 2015

Published for Opposition

Tuesday, February 23, 2016

Cancellation Date

Friday, November 25, 2022

Trademark Owner History

Glaxo Group Limited - Original Registrant

Classifications

5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Trademark Events

Nov 25, 2022

Cancelled Sec. 8 (6-Yr)

Nov 8, 2022

Teas Change Of Correspondence Received

Nov 8, 2022

Attorney/Dom.Rep.Revoked And/Or Appointed

Nov 8, 2022

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

May 10, 2021

Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

Nov 3, 2016

Electronic Record Review Complete

May 10, 2016

Registered-Principal Register

Feb 23, 2016

Official Gazette Publication Confirmation E-Mailed

Feb 23, 2016

Published For Opposition

Feb 3, 2016

Notification Of Notice Of Publication E-Mailed

Jan 8, 2016

On Hold - Electronic Record Review Required

Nov 5, 2015

Approved For Pub - Principal Register

Nov 5, 2015

Examiner's Amendment Entered

Nov 5, 2015

Notification Of Examiners Amendment E-Mailed

Nov 5, 2015

Examiners Amendment E-Mailed

Nov 5, 2015

Examiners Amendment -Written

Nov 4, 2015

Assigned To Examiner

Jul 30, 2015

New Application Office Supplied Data Entered In Tram

Jul 28, 2015

New Application Entered In Tram